HECW2 Polyklonaler Antikörper

HECW2 Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 32026-1-PBS

Synonyme

NEDD4-like E3 ubiquitin-protein ligase 2, KIAA1301, HECT-type E3 ubiquitin transferase HECW2, HECT, C2 and WW domain-containing protein 2, EC:2.3.2.26



Geprüfte Anwendungen

Produktinformation

32026-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA HECW2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen HECW2 fusion protein Ag36316
Vollständiger Name HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
Berechnetes Molekulargewicht176 kDa,1572aa
Beobachtetes Molekulargewicht240 kDa
GenBank-ZugangsnummerXM_017004563.1
Gene symbol HECW2
Gene ID (NCBI) 57520
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

HECW2, also known as NEDL2 (Nedd4-like E3 ubiquitin-protein ligase 2), is a member of the HECT (Homologous to the E6-AP Carboxyl Terminus) family of E3 ubiquitin ligases. It is crucial in various pathophysiological processes, including cell proliferation, apoptosis, autophagy, immune response, and DNA damage repair (PMID: 39529070). HECW2 is known to stabilize and enhance the transcriptional activity of p73, a member of the p53 family of tumor suppressors, which promotes cell cycle arrest and apoptosis and has an essential role in neurodevelopment (PMID: 27389779). In cancer, HECW2 is a promising target for tumor therapy due to its role in regulating cell cycle progression and angiogenesis (PMID: 39529070). In neurodevelopmental disorders, variants in HECW2 have been reported to cause a disorder characterized by hypotonia, seizures, and impaired language (PMID: 34321324).